| Cellectis S.A.. (4/13/20). "Press Release: Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer". New York, NY. |
2020-04-13 |
| BioNTech SE. (4/9/20). "Press Release: Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development". Mainz & New York, NY. |
2020-04-09 |
| Seeqc, Inc.. (4/9/20). "Press Release: Seeqc Gains Over $11 Million in Funding to Introduce Fully Digital Quantum Computing". Elmsford, NY. |
2020-04-09 |
| Sophia Genetics S.A.. (4/8/20). "Press Release: Sophia Genetics Expands its Executive Team, Naming Lara Hashimoto Chief Business Officer". Lausanne & Boston, MA. |
2020-04-08 |
| Neuro Event Labs Oy. (4/8/20). "Press Release: Neuro Event Labs Closes €3.9M Series A Round to Become the Standard for Epilepsy Diagnostics". |
2020-04-08 |
| Avectas Ltd.. (4/8/20). "Press Release: Avectas Announces Issuance of U.S. Patent for Cell Engineering Technology by the U.S. Patent and Trademark Office". Dublin. |
2020-04-08 |
| Arrakis Therapeutics, Inc.. (4/8/20). "Press Release: Arrakis Therapeutics Enters Strategic Collaboration and License Agreement with Roche for Multi-Target Program Utilizing RNA-Targeted Small Molecule Drug Discovery Platform". Waltham, MA. |
2020-04-08 |
| Sirion Biotech GmbH. (4/7/20). "Press Release: Beam Therapeutics Licenses Sirion Biotech’s LentiBOOST Technology for Its CAR-T pipeline". Martinsried. |
2020-04-07 |
| Merck KGaA. (4/7/20). "Press Release: Merck Awarded Second U.S. Patent for CRISPR Gene-Editing Technology". Darmstadt. |
2020-04-07 |
| Apeptico Forschung und Entwicklung GmbH. (4/7/20). "Press Release: Solatide Has Been Approved by the Austrian Federal Office for Safety in Health Care for the Treatment of COVID-19 Patients with Severe Pulmonary Dysfunction". Vienna. |
2020-04-07 |
| Amphista Therapetuics. (4/7/20). "Press Release: Amphista Therapeutics Raises $7.5m Series A Round to Advance Targeted Protein Degradation Assets in Cancer". Glasgow. |
2020-04-07 |
| Gadeta B.V.. (4/7/20). "Press Release: Gadeta Appoints Marco Londei as Chief Executive Officer". Utrecht. |
2020-04-07 |
| Roche. (4/7/20). "Press Release: Roche Provides Regulatory Update on Risdiplam for the Treatment of Spinal Muscular Atrophy (SMA)". Basel. |
2020-04-07 |
| Evotec SE. (4/6/20). "Press Release: Evotec and Takeda Enter into Multi-year Gene Therapy Research Alliance". Hamburg. |
2020-04-06 |
| Izana Bioscience Ltd.. (4/6/20). "Press Release: Initiation of Two-centre Compassionate Use Study Involving Namilumab in the Treatment of Individual Patients with Rapidly Worsening COVID-19 Infection in Italy". Oxford. |
2020-04-06 |
| Sutura Therapeutics Ltd.. (4/6/20). "Press Release: Sutura Therapeutics Appoints Alex Smith as Head of Patient Advocacy". Birkenhead. |
2020-04-06 |
| BIO Deutschland. (4/6/20). "Press Release: German Biotechnology Companies Are Playing a Key Role in Combating the Corona Pandemic". Berlin. |
2020-04-06 |
| GlaxoSmithKline plc. (4/6/20). "Press Release: GSK and Vir Biotechnology Enter Collaboration to Find Coronavirus Solutions". London & San Francisco, CA. |
2020-04-06 |
| MorphoSys AG. (4/6/20). "Press Release: MorphoSys Provides Update on Impact of COVID-19 on Business Operations and Precautionary Measures". Planegg. |
2020-04-06 |
| Evotec SE. (4/6/20). "Press Release: Evotec Expands into Gene Therapy. Evotec Establishes Gene Therapy R&D Site with more than 20 Experienced Scientis in Austria". Hamburg. |
2020-04-06 |
| Symphogen A/S. (4/3/20). "Press Release: Servier Signed a Definitive Agreement to Acquire Symphogen, a Leading Antibody Discovery Company, to Boost Its Antibody Capabilities and Leverage Its R&D Pipeline". Paris & Copenhagen. |
2020-04-03 |
| ERS Genomics Ltd.. (4/2/20). "Press Release: ERS Genomics and Axxam Announce CRISPR/Cas9 License Agreement to Enhance Discovery Services". Dublin & Milan. |
2020-04-02 |
| Actimed Therapeutics Ltd.. (4/2/20). "Press Release: Actimed Therapeutics Appoints Annalisa Jenkins as Advisor". London. |
2020-04-02 |
| MolMed S.p.A. (at the request of AGC Inc.). (4/2/20). "Press Release: Offer Document Filed with Consob. Voluntary Public Tender Offer Launched by AGC Inc. on All the Ordinary Shares of MolMed S.p.A. [Not for release where violation of laws or regulations |
2020-04-02 |
| Apeiron Biologics AG. (4/2/20). "Press Release: Apeiron Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19". Vienna. |
2020-04-02 |
| Evotec SE. (4/2/20). "Press Release: Evotec Expands Its iPSC-based Cell Therapy Platform Evocells through Licensing Agreement with PanCella". Hamburg & Toronto. |
2020-04-02 |
| iTeos Therapeutics Inc.. (4/1/20). "Press Release: iTeos Therapeutics Closes $125 Million Series B2 Financing". Cambridge, MA & Gosselies. |
2020-04-01 |
| Neurimmune AG. (4/1/20). "Press Release: Neurimmune and Ethris Sign Collaboration Agreement to Rapidly Develop Inhaled mRNA-based Antibody Therapy for the Treatment of Covid-19". Zurich & Munich. |
2020-04-01 |
| Sutura Therapeutics Ltd.. (4/1/20). "Press Release: Sutura Therapeutics Appoints Mark Beards as Chief Executive Officer". Birkenhead. |
2020-04-01 |
| Evotec SE. (3/31/20). "Press Release: Evotec and Ildong to Collaborate with Development Projects on INDiGO Platform". Hamburg. |
2020-03-31 |
| Merck KGaA. (31/3/20). "Press Release: Merck Successfully Divests Allergopharma". Darmstadt. |
2020-03-31 |
| Qiagen N.V.. (3/31/20). "Press Release: Qiagen Receives U.S. FDA EUA for QIAstat-Dx Test Kit, First and Only Syndromic Solution Integrating Detection of SARS-CoV-2 Coronavirus". Germantown, MD & Hilden. |
2020-03-31 |
| AM-Pharma B.V.. (3/31/20). "Press Release: AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI". Utrecht. |
2020-03-31 |
| BioNTech SE. (3/31/20). "Press Release: BioNTech Announces Full Year 2019 Financial Results and Corporate Update". Mainz. |
2020-03-31 |
| Sitryx Therapeutics Ltd.. (3/31/20). "Press Release: Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines". Indianapolis, IN & Oxford. |
2020-03-31 |
| Exscientia Ltd.. (3/31/20). "Press Release: Exscientia Announces Joint Initiative to Identify COVID-19 Drugs with Diamond Light Source and Scripps Research". |
2020-03-31 |
| Danaher Corporation. (3/31/20). "Press Release: Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences, Business Will Be Called Cytiva". Washington, DC. |
2020-03-31 |
| InflaRx N.V.. (3/31/20). "Press Release: InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology". Jena. |
2020-03-31 |
| Gilde Healthcare Partners. (3/31/20). "Press Release: Gilde Healthcare Raises €416 million ($450 million) Venture and Growth Capital Fund". Utrecht & Cambridge, MA. |
2020-03-31 |
| Numab Therapeutics AG. (3/30/20). "Press Release: Numab Therapeutics Expands Immuno-Oncology Research Alliance with Ono Pharmaceutical Co., Ltd.". Wädenswil (Zurich). |
2020-03-30 |
| Owlstone Medical Ltd.. (3/30/20). "Press Release: Owlstone Medical Appoints Neil Tween as Chief Financial Officer". Cambridge. |
2020-03-30 |
| Boehringer Ingelheim. (3/30/20). "Press Release: Boehringer Ingelheim Opens Second Branch of Digital Lab BI X in Shanghai". Shanghai. |
2020-03-30 |
| ImaginAb, Inc.. (3/30/20). "Press Release: ImaginAb Announces Licensing Deal with AstraZeneca for CD8 ImmunoPET Technology". Los Angeles, CA. |
2020-03-30 |
| Biocat. (3/27/20). "Press Release: Barcelona to Host BIO-Europe Spring 2021". Barcelona. |
2020-03-27 |
| Evotec SE. (3/27/20). "Press Release: Evotec Statement on COVID-19 (last updated 27 March 2020)". Hamburg. |
2020-03-27 |
| H. Lundbeck A/S. (3/27/20). "Press Release: Lundbeck Announces Phase IIa Study Results of Lu AG06466 in Adults with Tourette Syndrome". Valby. |
2020-03-27 |
| H. Lundbeck A/S. (3/27/20). "Press Release: Lundbeck Reports Headline Results from Phase IIa AMBLED study of Foliglurax in Parkinson’s Disease". Valby. |
2020-03-27 |
| BioKryo GmbH. (3/27/20). "Press Release: BioKryo Biobanking Network Supports Clinical Trials". Sulzbach. |
2020-03-27 |
| Immune Regulation Ltd.. (3/27/20). "Press Release: Immune Regulation Ltd Appoints Jonathan Rigby as Chief Executive Officer". |
2020-03-27 |
| Evotec SE. (3/26/20). "Press Release: Evotec SE Fiscal Year 2019 Results". Hamburg. |
2020-03-26 |
| SutroVax, Inc.. (3/26/20). "Press Release: SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia". Foster City, CA. |
2020-03-26 |
| Sophia Genetics S.A.. (3/26/20). "Press Release: Sophia Genetics and Paragon Genomics Join Forces Against the COVID-19 Coronavirus Pandemic". Lausanne & Boston, MA. |
2020-03-26 |
| Randox Laboratories Ltd.. (3/26/20). "Press Release: Point of Care Coronavirus Test from Randox and Bosch Will Launch in April 2020". |
2020-03-26 |
| Medigene AG. (3/26/20). "Press Release: Medigene Provides Results for Fiscal Year 2019 and Outlook". Martinsried. |
2020-03-26 |
| Bone Therapeutics S.A.. (3/26/20). "Press Release: Bone Therapeutics Appoints Stefanos Theoharis as Chief Business Officer". Gosselies. |
2020-03-26 |
| Evox Therapeutics Ltd.. (3/26/20). "Press Release: Evox Therapeutics and Takeda Sign Multi-target Rare Disease Collaboration". |
2020-03-26 |
| MedinCell S.A.. (3/25/20). "Press Release: MedinCell Receives $ 6.4 Million Grant from Unitaid to Fight Malaria". Montpellier. |
2020-03-25 |
| Proteona Pte. Ltd.. (25/3/20). "Press Release: Proteona Leads International Consortium to Develop SARS-CoV-2 Neutralizing Antibody to Help Vulnerable Immunocompromised Individuals". Singapore. |
2020-03-25 |
| Debiopharm International SA. (3/25/20). "Press Release: Debiopharm Expands Its Radiopharmaceutical Footprint with an Exclusive In-licensing Agreement of 3B Pharmaceutical’s Targeted CAIX Radiotherapy". Lausanne. |
2020-03-25 |
| Forge Therapeutics, Inc.. (3/25/20). "Press Release: Forge Enters into Collaboration with Roche to Develop Novel Antibiotic to Treat Lung Infections". San Diego, CA. |
2020-03-25 |
| Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces R&D Update". London. |
2020-03-25 |
| Evotec SE. (3/25/20). "Press Release: Evotec Partner Forge Enters into Collaboration with Roche to Develop Novel Antibiotic". San Diego, CA. |
2020-03-25 |
| Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces Collaboration with AstraZeneca to Discover and Develop siRNA Therapeutics for Cardiovascular, Renal, Metabolic and Respiratory Diseases". London. |
2020-03-25 |
| Roche. (3/24/20). "Press Release: Roche Response to COVID-19 Pandemic". Basel. |
2020-03-24 |
| Qiagen N.V.. (3/24/20). "Press Release: Qiagen Names Thierry Bernard as Chief Executive Officer". Venlo, Hilden & Germantown, MD. |
2020-03-24 |
| ProBioGen AG. (3/24/20). "Press Release: Immunogenesis Contracts ProBioGen for Development and Large-Scale Manufacturing Services". Berlin & Houston, TX. |
2020-03-24 |
| Bayer AG. (23/3/20). "Press Release: Bayer and Curadev Sign Research Collaboration and License Agreement to Develop Novel STING Antagonists across Indications". Berlin & New Delhi. |
2020-03-23 |
| Roche. (3/23/20). "Press Release: Roche Announces Venclexta/Venclyxto Combination Improved Overall Survival in People with Previously Untreated Acute Myeloid Leukaemia". Basel. |
2020-03-23 |
| Proteona Pte. Ltd.. (23/3/20). "Press Release: One More Step towards True Precision Medicine. Proteona, Synovo, and NMI Announced Collaboration on a Single Cell Multi-omics Profiling Platform for Patient-derived Micro-tumors". Singapore. |
2020-03-23 |
| Genedata AG. (3/23/20). "Press Release: CytomX Therapeutics Deploys Genedata Bioprocess". South San Francisco, CA & Tokyo. |
2020-03-23 |
| AC Immune S.A.. (3/23/20). "Press Release: AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomer Tau Partnership". Lausanne. |
2020-03-23 |
| Eppendorf AG. (3/19/20). "Press Release: Eppendorf Acquires Centrifuge Business of Koki Holdings Co., Ltd.". Hamburg & Tokyo. |
2020-03-19 |
| ADC Therapeutics S.A.. (3/19/20). "Press Release: ADC Therapeutics to Appoint Ron Squarer as Chairman of Its Board of Directors and an Advisor to the Company". Lausanne. |
2020-03-19 |
| Oxford Biomedica plc. (3/18/20). "Press Release: Oxford BioMedica Signs License & Clinical Supply Agreement with Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, for LentiVector Platform for CAR-T and TCR-T Therapeutics". Oxford. |
2020-03-18 |
| Bristol-Myers Squibb Company. (3/18/20). "Press Release: Bristol Myers Squibb Appoints Elizabeth Mily as Executive Vice President, Strategy & Business Development". New York, NY. |
2020-03-18 |
| Oxford Biomedica plc. (3/18/20). "Press Release: Building the Group for Future Growth. Business Update". Oxford. |
2020-03-18 |
| OncoOne GmbH. (3/18/20). "Press Release: OncoOne Launches with EUR 13 Million Series A to Develop Multiple Drug Modalities for Unexplored Target". Klosterneuburg. |
2020-03-18 |
| ImCheck Therapeutics S.A.S.. (3/17/20). "Press Release: ImCheck Therapeutics Expands Leadership Team with Appointment of Hans Henrik Chrois Christensen as Chief Financial Officer and Chief Operating Officer". Marseille. |
2020-03-17 |
| NeoPhore Ltd.. (3/17/20). "Press Release: NeoPhore Appoints Dr Matthew Baker as Chief Executive Officer". Cambridge. |
2020-03-17 |
| Affimed N.V.. (3/17/20). "Press Release: Affimed Announces Appointment of Arndt Schottelius, M.D. Ph.D. as Chief Scientific Officer". Heidelberg. |
2020-03-17 |
| AGC Inc.. (3/17/20). "Press Release: AGC Decides to Launch Voluntary Tender Offer for Shares of MolMed". |
2020-03-17 |
| Immatics Biotechnologies GmbH. (3/17/20). "Press Release: Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies". Houston, TX & Tübingen. |
2020-03-17 |
| Evonik Industries AG. (3/17/20). "Press Release: Evonik Achieves Major Biotech Breakthrough with a New Animal-free and Fermentation-based Collagen Platform". |
2020-03-17 |
| BioNTech SE. (3/17/20). "Press Release: Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine". New York, NY & Mainz. |
2020-03-17 |
| BioNTech SE. (3/16/20). "Press Release: BioNTech Reports Rapid Progress on COVID-19 Vaccine Program to Address Global Public Health Threat". Mainz. |
2020-03-16 |
| BioNTech SE. (3/16/20). "Press Release: BioNTech and Fosun Pharma Form COVID-19 Vaccine Strategic Alliance in China". Mainz & Shanghai. |
2020-03-16 |
| CureVac AG. (3/16/20). "Press Release: CureVac Announces Leadership Update". Tübingen & Boston, MA. |
2020-03-16 |
| CureVac AG. (3/15/20). "Press Release: CureVac Focuses on the Development of mRNA-based Coronavirus Vaccine to Protect People Worldwide. The Company Rejects Current Rumors of an Acquisition". Tübingen & Boston, MA. |
2020-03-15 |
| dievini Hopp BioTech holding GmbH & Co. KG. (3/15/20). "Press Release: dievini nimmt Stellung zu Presseveröffentlichungen über ihre Beteiligungsgesellschaft". Walldorf. |
2020-03-15 |
| Tempus Labs, Inc.. (3/13/20). "Press Release: Tempus Announces $100 Million in Series G Financing". |
2020-03-13 |
| Life Science Nord Management GmbH. (3/11/20). "Press Release: Innovation Project Started – Digital Precision Medicine Made in Northern Germany". |
2020-03-11 |
| CureVac AG. (3/11/20). "Press Release: Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG". Tübingen & Boston, MA. |
2020-03-11 |
| Genedata AG. (3/10/20). "Press Release: Chugai Implements Genedata Profiler to Accelerate Data-driven Biomarker Discovery". Tokyo. |
2020-03-10 |
| MedDay Pharmaceuticals S.A.S.. (3/10/20). "Press Release: MedDay Reports Top-line Data from Phase III Trial »SPI2« for Treatment of Progressive Forms of Multiple Sclerosis". Paris. |
2020-03-10 |
| Thermo Fisher Scientific Inc.. (3/10/20). "Press Release: Thermo Fisher Scientific Names Paul G. Parker to Head Strategy and Corporate Development". Waltham, MA. |
2020-03-10 |
| Life Sciences Partners (LSP). (3/10/20). "Press Release: LSP Closes Largest Ever European Life Sciences Fund at $600 Million". Amsterdam, Munich & Boston, MA. |
2020-03-10 |
| MolMed S.p.A.. (3/9/20). "Press Release: The Board of Directors Approved the 2019 Full Year Financial Results". Milan. |
2020-03-09 |
| Calixar S.A.S.. (3/9/20). "Press Release: Calixar Launches New Funding Round to Establish Business Strategy". Lyon. |
2020-03-09 |
| UCB S.A.. (3/9/20). "Press Release: UCB Announces Appointment of Sandrine Dufour as New Chief Financial Officer". Brussels. |
2020-03-09 |
| Genomics plc. (3/9/20). "Press Release: Mitchell Harris Joins Genomics plc as Chief Strategy Officer". Oxford. |
2020-03-09 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo-2019.png){kind=logo}
1 2 3 4 ... 171 172 173 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
